<DOC>
	<DOCNO>NCT02178813</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability high-dose minocycline patient population undergo carotid revascularization procedure , namely carotid endarterectomy ( CEA ) carotid artery stenting ( CAS ) . Establishment safety facilitate proceed phase II trial . During trial , patient undergo carotid revascularization procedure receive high dos minocycline follow schedule ( base previous trial ) : - Day prior procedure : 800mg orally ( p.o ) , 700mg p.o . - Day procedure : 600mg intravenously ( i.v . ) , 500mg p.o . - Day procedure : 400mg p.o. , 400mg p.o . The level drug plasma , standard blood test ( complete blood count , creatinine , liver function test ) well marker neuronal injury ( Neuron specific enolase , protein- S100b ) inflammation ( C-reactive protein ) also monitor . The patient monitor closely development side effect minocycline . MRI image use follow development small stroke result revascularization procedure resolution . The patient study , receive peri-operative minocycline , compare historical control regard development small stroke persistent stroke subsequent MRI imaging .</brief_summary>
	<brief_title>The Safety High Dose Minocycline Patient Population Undergoing Carotid Revascularization</brief_title>
	<detailed_description />
	<mesh_term>Minocycline</mesh_term>
	<criteria>1 . Patients clinical indication carotid revascularization ( CRV ) decide treat physician ( clinical indication CRV well choice type CRV , either CEA CAS , entirely treat physician ) 2 . Patients perform neurocognitive test English 3 . Women childbearing age nonlactating negative pregnancy test 4 . Patients age range 18 year 90 year 5 . Patients able undergo MRI imaging . 6 . Patients dependable able return followup study exams . 7 . Patients hospital ( inpatient ) day prior procedure clinical purpose ( evaluation side effect first dose overnight infusion minocycline procedure ) 1 . Known hypersensitivity tetracycline 2 . Significant neurological deficit include limited dense aphasia , hemi monoparesis ( motor strength equal le 3/5 ) neglect . 3 . Baseline abnormalities MRI brain would preclude detection new DWI FLAIR change . ( e.g large area acute stroke , large area previous encephalomalacia , exist hardware aneurysm clip coil mass etc . ) 4 . Patients pregnant , breastfeeding , lactate . 5 . Patients contraindication undergo MRI , include pacemaker , metal implant metal fragment within body . 6 . Patients abnormal liver function test baseline define 2fold elevation alanineaminotransferase . 7 . Patients significantly affect renal function baseline ( Creatinine equal 2mg/dL ) . 8 . Patients high dose isotretinoin , vitamin A , methotrexate 9 . Patients undergoing emergency carotid revascularization procedure . 10 . Any clinically important know medical , surgical , psychiatric psychological disease , would preclude completion protocol ( advanced cardiac , renal pulmonary disease ) .We screen physical mental capacity undergo study procedure obtain proxy consent subject appear decisionally impair . The screening process perform physician coinvestigator obtain informed consent . 11 . Patients MiniMental Status Exam score ( MMSE ) less 21 ( determine one coinvestigators ) . Patients MMSE score 21 include . 12 . Patients undergo carotid revascularization le 36 hour identification , patient undecided participation le 36 hour prior procedure eligible study . 13 . Patients factor would make followup study difficult ( e.g patient another country , patient prisoner )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Minocycline</keyword>
	<keyword>Neuroprotection</keyword>
	<keyword>Stroke</keyword>
</DOC>